Approval · Notice of Compliance 25957 · 2021
INCREXXA: Notice of Compliance 25957
Issued June 1, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 25957
- Date
- June 1, 2021
- Company
- Elanco Canada LimitedGuelph, Ontario, Canada
- Product type
- Veterinary
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- DRAXXIN (Zoetis Canada Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| INCREXXA | Not yet assigned | — |
Medicinal ingredients
- TULATHROMYCIN 100 MG per ML